Viral strategies for the evasion of immunogenic cell death: Symposium

Journal of Internal Medicine

Volumn 267, Issue 5, 2010, Pages 526-542

  Galluzzi, L ^a,b   Kepp, O ^a,b   Morselli, E ^a,b   Vitale, I ^a,b   Senovilla, L ^a,b   Pinti, M ^c   Zitvogel, L ^a,b   Kroemer, G ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

BAP31; Bax; Calreticulin; Caspases; Eif2 ; PERK

Indexed keywords

ADENOSINE DEAMINASE; CALNEXIN; CALRETICULIN; DOUBLE STRANDED RNA; INITIATION FACTOR 2ALPHA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PHOSPHOPROTEIN PHOSPHATASE; POLYADENYLIC ACID BINDING PROTEIN; PROTEIN KINASE; RNA BINDING PROTEIN; SYNAPTOBREVIN 1; VIRUS PROTEIN;

ADENOVIRUS; APOPTOSIS; BACULOVIRUS; CELL DEATH; CELL SURFACE; CONFERENCE PAPER; CYTOMEGALOVIRUS; DENDRITIC CELL; EBOLA VIRUS; ENDOPLASMIC RETICULUM STRESS; EPSTEIN BARR VIRUS; GENE TRANSLOCATION; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HOST RESISTANCE; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN PAPILLOMAVIRUS TYPE 18; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLUENZA VIRUS; MOLECULAR MECHANICS; MYXOMA VIRUS; NONHUMAN; PHAGOCYTOSIS; POXVIRUS; PRIORITY JOURNAL; REOVIRUS; ROTAVIRUS; SENDAI VIRUS; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS INTERFERENCE; VIRUS RESISTANCE; VIRUS TRANSMISSION; WART VIRUS;

ANIMALS; APOPTOSIS; HUMANS; MICE; NEOPLASMS; VIRUS PHYSIOLOGICAL PROCESSES;

EID: 77950499409     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02223.x     Document Type: Conference Paper

References (168)

1. Finlay BB, McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 2006 124 : 767 782. (Pubitemid 43261451)
2. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog 2008 4 : e1000018. (Pubitemid 351811512)
3. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol Rev 2007 87 : 99 163. (Pubitemid 46209992)
4. Kroemer G, Galluzzi L, Vandenabeele P et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009 16 : 3 11.
5. Galluzzi L, Kroemer G. Necroptosis: a specialized pathway of programmed necrosis. Cell 2008 135 : 1161 1163.
6. Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci 2007 32 : 37 43. (Pubitemid 46043552)
7. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009 9 : 353 363.
8. Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Curr Opin Oncol 2009 21 : 71 6.
9. Obeid M, Tesniere A, Panaretakis T et al. Ecto-calreticulin in immunogenic chemotherapy. Immunol Rev 2007 220 : 22 34. (Pubitemid 350045569)
10. Obeid M, Tesniere A, Ghiringhelli F et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007 13 : 54 61. (Pubitemid 46067386)
11. Apetoh L, Ghiringhelli F, Tesniere A et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007 13 : 1050 1059. (Pubitemid 47517504)
12. Tesniere A, Schlemmer F, Kepp O et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 2010 29 : 482 491.
13. Ghiringhelli F, Apetoh L, Tesniere A et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 2009 15 : 1170 1178.
14. Kepp O, Tesniere A, Schlemmer F et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009 14 : 364 375.
15. Panaretakis T, Joza N, Modjtahedi N et al. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death. Cell Death Differ 2008 15 : 1499 1509.
16. Panaretakis T, Kepp O, Brockmeier U et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009 28 : 578 590.
17. Balachandran S, Barber GN. PKR in innate immunity, cancer, and viral oncolysis. Methods Mol Biol 2007 383 : 277 301.
18. Yan W, Frank CL, Korth MJ et al. Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK. Proc Natl Acad Sci USA 2002 99 : 15920 15925. (Pubitemid 35462724)
19. Talloczy Z, Virgin HWt, Levine B. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2006 2 : 24 9. (Pubitemid 43310359)
20. Garcia MA, Meurs EF, Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007 89 : 799 811.
21. Raven JF, Koromilas AE. PERK and PKR: old kinases learn new tricks. Cell Cycle 2008 7 : 1146 1150.
22. Der SD, Yang YL, Weissmann C, Williams BR. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. Proc Natl Acad Sci USA 1997 94 : 3279 3283.
23. Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem Soc Trans 2006 34 : 7 11.
24. Cardin E, Latreille M, Khoury C, Greenwood MT, Larose L. Nck-1 selectively modulates eIF2alphaSer51 phosphorylation by a subset of eIF2alpha-kinases. FEBS J 2007 274 : 5865 5875. (Pubitemid 350045800)
25. He B. Viruses, endoplasmic reticulum stress, and interferon responses. Cell Death Differ 2006 13 : 393 403.
26. Kepp O, Senovilla L, Galluzzi L et al. Viral subversion of immunogenic cell death. Cell Cycle 2009 8 : 860 869.
27. Novoa I, Zeng H, Harding HP, Ron D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J Cell Biol 2001 153 : 1011 1022. (Pubitemid 34289240)
28. Kawagishi-Kobayashi M, Cao C, Lu J, Ozato K, Dever TE. Pseudosubstrate inhibition of protein kinase PKR by swine pox virus C8L gene product. Virology 2000 276 : 424 434.
29. Pavio N, Romano PR, Graczyk TM, Feinstone SM, Taylor DR. Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2alpha kinase PERK. J Virol 2003 77 : 3578 3585. (Pubitemid 36297277)
30. Dar AC, Sicheri F. X-ray crystal structure and functional analysis of vaccinia virus K3L reveals molecular determinants for PKR subversion and substrate recognition. Mol Cell 2002 10 : 295 305. (Pubitemid 35007344)
31. Ramelot TA, Cort JR, Yee AA et al. Myxoma virus immunomodulatory protein M156R is a structural mimic of eukaryotic translation initiation factor eIF2alpha. J Mol Biol 2002 322 : 943 954.
32. Brand SR, Kobayashi R, Mathews MB. The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR. J Biol Chem 1997 272 : 8388 8395. (Pubitemid 27147798)
33. Romano PR, Zhang F, Tan SL et al. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol Cell Biol 1998 18 : 7304 7316. (Pubitemid 28533050)
34. Sharp TV, Moonan F, Romashko A, Joshi B, Barber GN, Jagus R. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation. Virology 1998 250 : 302 315. (Pubitemid 28489630)
35. Mulvey M, Arias C, Mohr I. Maintenance of endoplasmic reticulum (ER) homeostasis in herpes simplex virus type 1-infected cells through the association of a viral glycoprotein with PERK, a cellular ER stress sensor. J Virol 2007 81 : 3377 3390. (Pubitemid 46456647)
36. Cassady KA. Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J Virol 2005 79 : 8707 8715.
37. Valchanova RS, Picard-Maureau M, Budt M, Brune W. Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 2006 80 : 10181 10190. (Pubitemid 44522611)
38. Child SJ, Hanson LK, Brown CE, Janzen DM, Geballe AP. Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 2006 80 : 10173 10180.
39. Child SJ, Geballe AP. Binding and relocalization of protein kinase R by murine cytomegalovirus. J Virol 2009 83 : 1790 1799.
40. Li S, Min JY, Krug RM, Sen GC. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006 349 : 13 21.
41. Dever TE, Sripriya R, McLachlin JR et al. Disruption of cellular translational control by a viral truncated eukaryotic translation initiation factor 2alpha kinase homolog. Proc Natl Acad Sci USA 1998 95 : 4164 4169. (Pubitemid 28207882)
42. Poppers J, Mulvey M, Perez C, Khoo D, Mohr I. Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J Virol 2003 77 : 228 236. (Pubitemid 36004963)
43. Mulvey M, Poppers J, Sternberg D, Mohr I. Regulation of eIF2alpha phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J Virol 2003 77 : 10917 10928. (Pubitemid 37204285)
44. Burysek L, Pitha PM. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 2001 75 : 2345 2352. (Pubitemid 32147573)
45. Schumann M, Gantke T, Muhlberger E. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol 2009 83 : 8993 8997.
46. Hebner CM, Wilson R, Rader J, Bidder M, Laimins LA. Human papillomaviruses target the double-stranded RNA protein kinase pathway. J Gen Virol 2006 87 : 3183 3193. (Pubitemid 44608353)
47. Hakki M, Marshall EE, De Niro KL, Geballe AP. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. J Virol 2006 80 : 11817 11826.
48. Takeuchi K, Komatsu T, Kitagawa Y, Sada K, Gotoh B. Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. J Virol 2008 82 : 10102 10110.
49. Gonzalez-Lopez C, Martinez-Costas J, Esteban M, Benavente J. Evidence that avian reovirus sigmaA protein is an inhibitor of the double-stranded RNA-dependent protein kinase. J Gen Virol 2003 84 : 1629 1639.
50. Hakki M, Geballe AP. Double-stranded RNA binding by human cytomegalovirus pTRS1. J Virol 2005 79 : 7311 7318.
51. Bryant KF, Cox JC, Wang H, Hogle JM, Ellington AD, Coen DM. Binding of herpes simplex virus-1 US11 to specific RNA sequences. Nucleic Acids Res 2005 33 : 6090 6100.
52. Cassady KA, Gross M, Roizman B. The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2. J Virol 1998 72 : 8620 8626.
53. Goodman AG, Smith JA, Balachandran S et al. The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol 2007 81 : 2221 2230. (Pubitemid 46303340)
54. Clerzius G, Gelinas JF, Daher A, Bonnet M, Meurs EF, Gatignol A. ADAR1 interacts with PKR during HIV infection of lymphocytes and contributes to viral replication. J Virol 2009 83 : 10119 10128.
55. Daher A, Laraki G, Singh M et al. TRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress. Mol Cell Biol 2009 29 : 254 265.
56. Peters GA, Khoo D, Mohr I, Sen GC. Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein. J Virol 2002 76 : 11054 11064. (Pubitemid 35176222)
57. Wahid AM, Coventry VK, Conn GL. Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase. J Biol Chem 2008 283 : 17485 17493.
58. He B, Gross M, Roizman B. The gamma134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J Biol Chem 1998 273 : 20737 20743. (Pubitemid 28385349)
59. He B, Gross M, Roizman B. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 1997 94 : 843 848. (Pubitemid 27074409)
60. Kazemi S, Papadopoulou S, Li S et al. Control of alpha subunit of eukaryotic translation initiation factor 2 (eIF2 alpha) phosphorylation by the human papillomavirus type 18 E6 oncoprotein: implications for eIF2 alpha-dependent gene expression and cell death. Mol Cell Biol 2004 24 : 3415 3429. (Pubitemid 38452084)
61. Montero H, Rojas M, Arias CF, Lopez S. Rotavirus infection induces the phosphorylation of eIF2alpha but prevents the formation of stress granules. J Virol 2008 82 : 1496 1504.
62. Seo EJ, Liu F, Kawagishi-Kobayashi M et al. Protein kinase PKR mutants resistant to the poxvirus pseudosubstrate K3L protein. Proc Natl Acad Sci USA 2008 105 : 16894 16899.
63. Rothenburg S, Seo EJ, Gibbs JS, Dever TE, Dittmar K. Rapid evolution of protein kinase PKR alters sensitivity to viral inhibitors. Nat Struct Mol Biol 2009 16 : 63 70.
64. Casares N, Pequignot MO, Tesniere A et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005 202 : 1691 1701. (Pubitemid 41815875)
65. Lavrik I, Golks A, Krammer PH. Death receptor signaling. J Cell Sci 2005 118 : 265 267. (Pubitemid 40277339)
66. Lavrik I, Krueger A, Schmitz I et al. The active caspase-8 heterotetramer is formed at the CD95 DISC. Cell Death Differ 2003 10 : 144 145.
67. Park MA, Zhang G, Martin AP et al. Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation. Cancer Biol Ther 2008 7 : 1648 1662.
68. Zhang G, Park MA, Mitchell C et al. Vorinostat and sorafenib synergistically kill tumor cells via FLIP suppression and CD95 activation. Clin Cancer Res 2008 14 : 5385 5399.
69. Fischer U, Stroh C, Schulze-Osthoff K. Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene 2006 25 : 152 159. (Pubitemid 43050014)
70. Timmer JC, Salvesen GS. Caspase substrates. Cell Death Differ 2007 14 : 66 72.
71. Stennicke HR, Jurgensmeier JM, Shin H et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem 1998 273 : 27084 27090.
72. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998 94 : 491 501. (Pubitemid 28391865)
73. Ng FW, Shore GC. Bcl-XL cooperatively associates with the Bap31 complex in the endoplasmic reticulum, dependent on procaspase-8 and Ced-4 adaptor. J Biol Chem 1998 273 : 3140 3143.
74. Ng FW, Nguyen M, Kwan T et al. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum. J Cell Biol 1997 139 : 327 338.
75. Wang B, Nguyen M, Breckenridge DG et al. Uncleaved BAP31 in association with A4 protein at the endoplasmic reticulum is an inhibitor of Fas-initiated release of cytochrome c from mitochondria. J Biol Chem 2003 278 : 14461 14468. (Pubitemid 36799999)
76. Nguyen M, Breckenridge DG, Ducret A, Shore GC. Caspase-resistant BAP31 inhibits Fas-mediated apoptotic membrane fragmentation and release of cytochrome c from mitochondria. Mol Cell Biol 2000 20 : 6731 6740.
77. Breckenridge DG, Stojanovic M, Marcellus RC, Shore GC. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J Cell Biol 2003 160 : 1115 1127.
78. 2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ 2008 15 : 274 282.
79. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008 9 : 47 59.
80. Zhou Q, Snipas S, Orth K, Muzio M, Dixit VM, Salvesen GS. Target protease specificity of the viral serpin CrmA. Analysis of five caspases. J Biol Chem 1997 272 : 7797 7800. (Pubitemid 27137336)
81. Komiyama T, Ray CA, Pickup DJ et al. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 1994 269 : 19331 19337. (Pubitemid 24978752)
82. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998 273 : 32608 32613.
83. Muzio M, Salvesen GS, Dixit VM. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens. J Biol Chem 1997 272 : 2952 2956. (Pubitemid 27053346)
84. MacNeill AL, Turner PC, Moyer RW. Mutation of the myxoma virus SERP2 P1-site to prevent proteinase inhibition causes apoptosis in cultured RK-13 cells and attenuates disease in rabbits, but mutation to alter specificity causes apoptosis without reducing virulence. Virology 2006 356 : 12 22.
85. Xu G, Rich RL, Steegborn C et al. Mutational analyses of the p35-caspase interaction. A bowstring kinetic model of caspase inhibition by p35. J Biol Chem 2003 278 : 5455 5461. (Pubitemid 36801062)
86. Xu G, Cirilli M, Huang Y, Rich RL, Myszka DG, Wu H. Covalent inhibition revealed by the crystal structure of the caspase-8/p35 complex. Nature 2001 410 : 494 497. (Pubitemid 32240052)
87. Zoog SJ, Schiller JJ, Wetter JA, Chejanovsky N, Friesen PD. Baculovirus apoptotic suppressor P49 is a substrate inhibitor of initiator caspases resistant to P35 in vivo. EMBO J 2002 21 : 5130 5140.
88. Zhou Q, Krebs JF, Snipas SJ et al. Interaction of the baculovirus anti-apoptotic protein p35 with caspases. Specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 1998 37 : 10757 10765. (Pubitemid 28357877)
89. Jabbour AM, Ekert PG, Coulson EJ, Knight MJ, Ashley DM, Hawkins CJ. The p35 relative, p49, inhibits mammalian and Drosophila caspases including DRONC and protects against apoptosis. Cell Death Differ 2002 9 : 1311 1320.
90. Filippova M, Johnson MM, Bautista M et al. The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol 2007 81 : 4116 4129.
91. Skaletskaya A, Bartle LM, Chittenden T, McCormick AL, Mocarski ES, Goldmacher VS. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci USA 2001 98 : 7829 7834. (Pubitemid 32642646)
92. Filippova M, Song H, Connolly JL, Dermody TS, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem 2002 277 : 21730 21739.
93. Bertin J, Armstrong RC, Ottilie S et al. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc Natl Acad Sci USA 1997 94 : 1172 1176. (Pubitemid 27087823)
94. Hu S, Vincenz C, Buller M, Dixit VM. A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J Biol Chem 1997 272 : 9621 9624.
95. Thome M, Schneider P, Hofmann K et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997 386 : 517 521. (Pubitemid 27164081)
96. Nakagiri S, Murakami A, Takada S, Akiyama T, Yonehara S. Viral FLIP enhances Wnt signaling downstream of stabilized beta-catenin, leading to control of cell growth. Mol Cell Biol 2005 25 : 9249 9258.
97. Glykofrydes D, Niphuis H, Kuhn EM et al. Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity. J Virol 2000 74 : 11919 11927. (Pubitemid 32222342)
98. Sturzl M, Hohenadl C, Zietz C et al. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1999 91 : 1725 1733.
99. Belanger C, Gravel A, Tomoiu A et al. Human herpesvirus 8 viral FLICE-inhibitory protein inhibits Fas-mediated apoptosis through binding and prevention of procaspase-8 maturation. J Hum Virol 2001 4 : 62 73. (Pubitemid 32577088)
100. Shisler JL, Moss B. Molluscum contagiosum virus inhibitors of apoptosis: the MC159 v-FLIP protein blocks Fas-induced activation of procaspases and degradation of the related MC160 protein. Virology 2001 282 : 14 25.
101. Saito K, Meyer K, Warner R, Basu A, Ray RB, Ray R. Hepatitis C virus core protein inhibits tumor necrosis factor alpha-mediated apoptosis by a protective effect involving cellular FLICE inhibitory protein. J Virol 2006 80 : 4372 4379.
102. Snow AL, Lambert SL, Natkunam Y, Esquivel CO, Krams SM, Martinez OM. EBV can protect latently infected B cell lymphomas from death receptor-induced apoptosis. J Immunol 2006 177 : 3283 3293. (Pubitemid 44277848)
103. Krueger A, Fas SC, Giaisi M et al. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP). Blood 2006 107 : 3933 3939.
104. Gibellini D, Re MC, Ponti C et al. HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity. J Cell Physiol 2005 203 : 547 556. (Pubitemid 40629017)
105. Regan JA, Laimins LA. Bap31 is a novel target of the human papillomavirus E5 protein. J Virol 2008 82 : 10042 10051.
106. Han J, Sabbatini P, Perez D, Rao L, Modha D, White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev 1996 10 : 461 477.
107. Lomonosova E, Subramanian T, Chinnadurai G. Mitochondrial localization of p53 during adenovirus infection and regulation of its activity by E1B-19K. Oncogene 2005 24 : 6796 6808. (Pubitemid 41487038)
108. Wasilenko ST, Stewart TL, Meyers AF, Barry M. Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis. Proc Natl Acad Sci USA 2003 100 : 14345 14350. (Pubitemid 37499239)
109. Postigo A, Cross JR, Downward J, Way M. Interaction of F1L with the BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell Death Differ 2006 13 : 1651 1662. (Pubitemid 44390853)
110. Wasilenko ST, Banadyga L, Bond D, Barry M. The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J Virol 2005 79 : 14031 14043. (Pubitemid 41552701)
111. Taylor JM, Quilty D, Banadyga L, Barry M. The vaccinia virus protein F1L interacts with Bim and inhibits activation of the pro-apoptotic protein Bax. J Biol Chem 2006 281 : 39728 39739. (Pubitemid 46041932)
112. Banadyga L, Gerig J, Stewart T, Barry M. Fowlpox virus encodes a Bcl-2 homologue that protects cells from apoptotic death through interaction with the proapoptotic protein Bak. J Virol 2007 81 : 11032 11045. (Pubitemid 47536076)
113. Banadyga L, Veugelers K, Campbell S, Barry M. The fowlpox virus BCL-2 homologue, FPV039, interacts with activated Bax and a discrete subset of BH3-only proteins to inhibit apoptosis. J Virol 2009 83 : 7085 7098.
114. Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J 2002 21 : 2602 2615. (Pubitemid 34619376)
115. You RI, Chen MC, Wang HW, Chou YC, Lin CH, Hsieh SL. Inhibition of lymphotoxin-beta receptor-mediated cell death by survivin-DeltaEx3. Cancer Res 2006 66 : 3051 3061.
116. Virgin HWT, Latreille P, Wamsley P et al. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 1997 71 : 5894 5904. (Pubitemid 27304926)
117. Wang GH, Garvey TL, Cohen JI. The murine gammaherpesvirus-68 M11 protein inhibits Fas- and TNF-induced apoptosis. J Gen Virol 1999 10 : 2737 2740.
118. McCormick AL, Smith VL, Chow D, Mocarski ES. Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis. J Virol 2003 77 : 631 641. (Pubitemid 36005000)
119. Arnoult D, Bartle LM, Skaletskaya A et al. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. Proc Natl Acad Sci USA 2004 101 : 7988 7993. (Pubitemid 38698041)
120. Pauleau AL, Larochette N, Giordanetto F et al. Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA. Oncogene 2007 26 : 7067 7080. (Pubitemid 350059674)
121. Afonso CL, Neilan JG, Kutish GF, Rock DL. An African swine fever virus Bc1-2 homolog, 5-HL, suppresses apoptotic cell death. J Virol 1996 70 : 4858 4863.
122. Neilan JG, Lu Z, Afonso CL, Kutish GF, Sussman MD, Rock DL. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J Virol 1993 67 : 4391 4394. (Pubitemid 23180769)
123. Cheng EH, Nicholas J, Bellows DS et al. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci USA 1997 94 : 690 694. (Pubitemid 27053695)
124. Huang Q, Petros AM, Virgin HW, Fesik SW, Olejniczak ET. Solution structure of a Bcl-2 homolog from Kaposi sarcoma virus. Proc Natl Acad Sci USA 2002 99 : 3428 3433. (Pubitemid 34252125)
125. Douglas AE, Corbett KD, Berger JM, McFadden G, Handel TM. Structure of M11L: a myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2. Protein Sci 2007 16 : 695 703.
126. Aoyagi M, Zhai D, Jin C et al. Vaccinia virus N1L protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 2007 16 : 118 124. (Pubitemid 46036504)
127. Su J, Wang G, Barrett JW, Irvine TS, Gao X, McFadden G. Myxoma virus M11L blocks apoptosis through inhibition of conformational activation of Bax at the mitochondria. J Virol 2006 80 : 1140 1151. (Pubitemid 43134071)
128. Wang G, Barrett JW, Nazarian SH et al. Myxoma virus M11L prevents apoptosis through constitutive interaction with Bak. J Virol 2004 78 : 7097 7111. (Pubitemid 38781548)
129. Cooray S, Bahar MW, Abrescia NG et al. Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 2007 88 : 1656 1666. (Pubitemid 46850584)
130. Marshall WL, Yim C, Gustafson E et al. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 1999 73 : 5181 5185. (Pubitemid 29246784)
131. Hickish T, Robertson D, Clarke P et al. Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. Cancer Res 1994 54 : 2808 2811. (Pubitemid 24173779)
132. Altmann M, Hammerschmidt W. Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis. PLoS Biol 2005 3 : e404. (Pubitemid 41796330)
133. Howell M, Williams T, Hazlewood SA. Herpesvirus pan encodes a functional homologue of BHRF1, the Epstein-Barr virus v-Bcl-2. BMC Microbiol 2005 5 : 6.
134. Meseda CA, Arrand JR, Mackett M. Herpesvirus papio encodes a functional homologue of the Epstein-Barr virus apoptosis suppressor, BHRF1. J Gen Virol 2000 81 : 1801 1805.
135. Derfuss T, Fickenscher H, Kraft MS et al. Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activity. J Virol 1998 72 : 5897 5904.
136. Nava VE, Cheng EH, Veliuona M et al. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 1997 71 : 4118 4122. (Pubitemid 27172431)
137. Westphal D, Ledgerwood EC, Hibma MH, Fleming SB, Whelan EM, Mercer AA. A novel Bcl-2-like inhibitor of apoptosis is encoded by the parapoxvirus ORF virus. J Virol 2007 81 : 7178 7188. (Pubitemid 46986654)
138. Valentijn K, Valentijn JA, Jamieson JD. Role of actin in regulated exocytosis and compensatory membrane retrieval: insights from an old acquaintance. Biochem Biophys Res Commun 1999 266 : 652 661. (Pubitemid 30042490)
139. Eletto D, Russo G, Passiatore G et al. Inhibition of SNAP25 expression by HIV-1 Tat involves the activity of mir-128a. J Cell Physiol 2008 216 : 764 770.
140. Mettenleiter TC. Budding events in herpesvirus morphogenesis. Virus Res 2004 106 : 167 180.
141. Pieren M, Galli C, Denzel A, Molinari M. The use of calnexin and calreticulin by cellular and viral glycoproteins. J Biol Chem 2005 280 : 28265 28271. (Pubitemid 41105722)
142. Zhu J, Newkirk MM. Viral induction of the human autoantigen calreticulin. Clin Invest Med 1994 17 : 196 205. (Pubitemid 24204865)
143. Bolt G. The measles virus (MV) glycoproteins interact with cellular chaperones in the endoplasmic reticulum and MV infection upregulates chaperone expression. Arch Virol 2001 146 : 2055 2068. (Pubitemid 33145582)
144. Braakman I, van Anken E. Folding of viral envelope glycoproteins in the endoplasmic reticulum. Traffic 2000 1 : 533 539.
145. Chignard N, Shang S, Wang H et al. Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: detection of generated fragments in patient sera. Gastroenterology 2006 130 : 2010 2022. (Pubitemid 43816962)
146. Galluzzi L, Aaronson SA, Abrams J et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ 2009 16 : 1093 1107.
147. Galluzzi L, Maiuri MC, Vitale I et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007 14 : 1237 1243. (Pubitemid 46969863)
148. Kroemer G, El-Deiry WS, Golstein P et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005 12 (Suppl. 2 1463 1467. (Pubitemid 41553979)
149. Desbien AL, Kappler JW, Marrack P. The Epstein-Barr virus Bcl-2 homolog, BHRF1, blocks apoptosis by binding to a limited amount of Bim. Proc Natl Acad Sci USA 2009 106 : 5663 5668.
150. Bai GQ, Cheng J, Zhang SL et al. Screening of hepatocyte proteins binding to complete S protein of hepatitis B virus by yeast-two hybrid system. World J Gastroenterol 2005 11 : 3899 3904. (Pubitemid 41025245)
151. Limjindaporn T, Wongwiwat W, Noisakran S et al. Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production. Biochem Biophys Res Commun 2009 379 : 196 200.
152. Choukhi A, Ung S, Wychowski C, Dubuisson J. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins. J Virol 1998 72 : 3851 3858. (Pubitemid 28188685)
153. Merola M, Brazzoli M, Cocchiarella F et al. Folding of hepatitis C virus E1 glycoprotein in a cell-free system. J Virol 2001 75 : 11205 11217. (Pubitemid 33031587)
154. Nakhasi HL, Ramanujam M, Atreya CD et al. Rubella virus glycoprotein interaction with the endoplasmic reticulum calreticulin and calnexin. Arch Virol 2001 146 : 1 14. (Pubitemid 32200751)
155. Veijola J, Pettersson RF. Transient association of calnexin and calreticulin with newly synthesized G1 and G2 glycoproteins of uukuniemi virus (family Bunyaviridae). J Virol 1999 73 : 6123 6127. (Pubitemid 29274905)
156. Laquerre S, Anderson DB, Argnani R, Glorioso JC. Herpes simplex virus type 1 glycoprotein B requires a cysteine residue at position 633 for folding, processing, and incorporation into mature infectious virus particles. J Virol 1998 72 : 4940 4949. (Pubitemid 28215673)
157. Singh NK, Atreya CD, Nakhasi HL. Identification of calreticulin as a rubella virus RNA binding protein. Proc Natl Acad Sci USA 1994 91 : 12770 12774.
158. Atreya CD, Singh NK, Nakhasi HL. The rubella virus RNA binding activity of human calreticulin is localized to the N-terminal domain. J Virol 1995 69 : 3848 3851.
159. Yocupicio-Monroy RM, Medina F, Reyes-del Valle J, del Angel RM. Cellular proteins from human monocytes bind to dengue 4 virus minus-strand 3′ untranslated region RNA. J Virol 2003 77 : 3067 3076. (Pubitemid 36228092)
160. Otteken A, Moss B. Calreticulin interacts with newly synthesized human immunodeficiency virus type 1 envelope glycoprotein, suggesting a chaperone function similar to that of calnexin. J Biol Chem 1996 271 : 97 103. (Pubitemid 26026563)
161. Land A, Braakman I. Folding of the human immunodeficiency virus type 1 envelope glycoprotein in the endoplasmic reticulum. Biochimie 2001 83 : 783 790. (Pubitemid 32821244)
162. Hebert DN, Foellmer B, Helenius A. Calnexin and calreticulin promote folding, delay oligomerization and suppress degradation of influenza hemagglutinin in microsomes. EMBO J 1996 15 : 2961 2968. (Pubitemid 26187744)
163. Daniels R, Kurowski B, Johnson AE, Hebert DN. N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin. Mol Cell 2003 11 : 79 90. (Pubitemid 36126592)
164. Tomita Y, Yamashita T, Sato H, Taira H. Kinetics of interactions of sendai virus envelope glycoproteins, F and HN, with endoplasmic reticulum-resident molecular chaperones, BiP, calnexin, and calreticulin. J Biochem 1999 126 : 1090 1100. (Pubitemid 30014456)
165. Wang N, Glidden EJ, Murphy SR, Pearse BR, Hebert DN. The cotranslational maturation program for the type II membrane glycoprotein influenza neuraminidase. J Biol Chem 2008 283 : 33826 33837.
166. Ding W, Albrecht B, Luo R et al. Endoplasmic reticulum and cis-Golgi localization of human T-lymphotropic virus type 1 p12(I): association with calreticulin and calnexin. J Virol 2001 75 : 7672 7682. (Pubitemid 32738025)
167. Alefantis T, Flaig KE, Wigdahl B, Jain P. Interaction of HTLV-1 Tax protein with calreticulin: implications for Tax nuclear export and secretion. Biomed Pharmacother 2007 61 : 194 200. (Pubitemid 46705478)
168. Hengel H, Koopmann JO, Flohr T et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 1997 6 : 623 632. (Pubitemid 27239353)